Help us reach further in Crohn’s disease

A clinical research study assessing the safety and effectiveness of an investigational drug for people with moderately to severely active Crohn’s disease (CD) is now enrolling.

If you are interested in taking part in the GALAXI Study, we are looking for men and women who:

They are other criteria that you will need to meet to qualify, which the study team will discuss with you.

For further information about the GALAXI study contact:

Macquarie University Hospital, Ray Yung, [email protected]
Nepean Hospital, Catherine Hemmings, [email protected]

The Mater hospital, Sharyn Grossman/Natalie Allan [email protected]
Princess Alexandra Hospital, Teressa Hansen, [email protected]

Royal Adelaide Hospital, Lorelle Smith & Julie McMahon, [email protected] or [email protected]
Queen Elizabeth Hospital, Lyndsay Bibb, [email protected]

Alfred Hospital, Julie Hogg, [email protected]
Austin Hospital, Kathryn Burrell, [email protected]
Monash Health, Thomas McLeod, [email protected]
Royal Melbourne Hospital, Irene Bell, [email protected]

Royal Perth Hospital, Veronique Isley, Stephanie Chislett, [email protected]

Contacting us does not mean that you will be obligated to join the study or that you will be eligible to participate.